As an ISG, LY6E has been shown to enhance the infection of Dengue virus, ZIKV, yellow fever virus, IAV, and VSV [52,53], while having dual effects on HIV-1 infection, promoting infection in CD4-high T cells and inhibiting it in CD4-low T cells [54,55]. Here, CD4 is linked to HIV-1 infection.